COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS-CARINII AND WILD-TYPEHUMAN DIHYDROFOLATE-REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[2,3-D]PYRIMIDINE ANTIFOLATE
V. Cody et al., COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS-CARINII AND WILD-TYPEHUMAN DIHYDROFOLATE-REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[2,3-D]PYRIMIDINE ANTIFOLATE, Acta crystallographica. Section D, Biological crystallography, 53, 1997, pp. 638-649
The novel furopyrimidine ,3-d]pyrimidin-5-yl)methyl]methylamino}benzoy
l)-L- glutamate (MTXO), a classical antifolate with antitumor activity
comparable to that of methotrexate (MTX), has been studied as inhibit
or-cofactor ternary crystal complexes with wild-type Pneumocystis cari
nii (pc) and recombinant human wild-type dihydrofolate reductase (hDHF
R). These structural data provide the first direct comparison of the b
inding interactions of the same antifolate inhibitor in the active sit
e for pc and human DHFR. The human ternary DHFR complex crystallizes i
n the rhombohedral space group R3 and is isomorphous to the ternary co
mplex reported for a gamma-tetrazole methotrexate analogue, MTXT. The
pcDHFR complex crystallizes in the monoclinic space group P2(1) and is
isomorphous to that reported for a trimethoprim (TMP) complex. Interp
retation of difference Fourier electron-density maps for these ternary
complexes revealed that MTXO binds with its 2,4-diaminofuropyrimidine
ring interacting with Glu32 in pc and Glu30 in human DHFR, as observe
d for MTXT. The presence of the 6-5 furopyrimidine ring instead of the
6-6 pteridine ring results in a different bridge conformation compare
d with that of MTXT. The bridge torsion angles for MTXO, i.e. C(4a)-C(
5)-C(8)-N(9) and C(5)-C(8)-N(9)-C(1'), are -156.5/51.9 degrees and -16
2.6/51.8 degrees, respectively for h and pc, compared with -146.8/57.4
degrees for MTXT. In each case, the p-aminobenzoylglutamate conformat
ion is similar to that observed for MTXT. In the pcDHFR complex, the a
ctive-site region is conserved and the additional 20 residues gin the
sequence compared with the human enzyme are located in external loop r
egions. There is a significant change in the nicotinamide ribose confo
rmation of the cofactor which places the nicotinamide O atom close to
the 4NH(2) group of MTXO (2.7 Angstrom), a shift not observed in hDHFR
structures. As a consequence of this, there is a loss of a hydrogen b
ond between the nicotinamide carbonyl group and the backbone of Ala12
in pcDHFR. In the human ternary complexes, the cofactor NADPH is bound
with a more extended conformation, and the nicotinamide O atom makes
a 3.5 Angstrom contact with the 4NH(2) group of MTXO. Although the nov
el classical antifolate MTXO is not highly active against pcDHFR, ther
e are correlations between its binding interactions consistent with it
s lower potency as an inhibitor of h and pcDHFR compared with MTX.